Literature DB >> 5933579

On the so-called metastasizing leiomyoma.

R H Sprio, C J McPeak.   

Abstract

Entities:  

Mesh:

Year:  1966        PMID: 5933579     DOI: 10.1002/1097-0142(196604)19:4<544::aid-cncr2820190412>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

1.  Pulmonary leiomyomatosis, a rare cause of miliary infiltrates. Report of two cases.

Authors:  D A Jamerson; R C Young; R L Simmons; C C Sampson
Journal:  J Natl Med Assoc       Date:  1976-01       Impact factor: 1.798

2.  Pulmonary lymphangiomyomatosis. A review.

Authors:  B Corrin; A A Liebow; P J Friedman
Journal:  Am J Pathol       Date:  1975-05       Impact factor: 4.307

3.  [Gynecological aspects of retroperitoneal diseases (author's transl)].

Authors:  V Jalůvka
Journal:  Arch Gynakol       Date:  1976-03-05

4.  Metastatic uterine leiomyosarcoma in association with recurrent lung abscess.

Authors:  N Sheron; M Griffiths; N M Johnson
Journal:  Thorax       Date:  1989-07       Impact factor: 9.139

5.  Leiomyoma of the uterus with bilateral pulmonary metastases.

Authors:  R Lefebvre; T Nawar; R Fortin; J Genest
Journal:  Can Med Assoc J       Date:  1971-09-04       Impact factor: 8.262

6.  Leiomyomatosis with vascular invasion. A unified pathogenesis regarding leiomyoma with vascular microinvasion, benign metastasizing leiomyoma and intravenous leiomyomatosis.

Authors:  V Canzonieri; E S D'Amore; G Bartoloni; M Piazza; S Blandamura; A Carbone
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Tricuspid stenosis due to intravenous leiomyomatosis--a call for caution: case report and review of the literature.

Authors:  M Nili; E Liban; M J Levy
Journal:  Tex Heart Inst J       Date:  1982-06

8.  Deep sequencing reveals the molecular pathology characteristics between primary uterine leiomyoma and pulmonary benign metastasizing leiomyoma.

Authors:  J Jiang; M He; X Hu; C Ni; L Yang
Journal:  Clin Transl Oncol       Date:  2018-02-26       Impact factor: 3.405

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.